Mount Sinai Announces Landmark Gift from James S. and Merryl H. Tisch to Transform Cancer Care in New York
$60 million pledged to establish the Mount Sinai Tisch Cancer Center and to construct a new, state-of-the-art cancer hospital in Manhattan
{To view the new Mount Sinai Tisch Cancer Center ad, watch here.}
Signaling a watershed moment for cancer care in the New York region, the Mount Sinai Health System today announced a game-changing $60 million gift from James S. and Merryl H. Tisch to establish the Mount Sinai Tisch Cancer Center. This gift will support the construction of a modern, state-of-the-art cancer hospital at the Mount Sinai Hospital campus. The Center will broaden access to breakthrough therapies, diagnostics, and clinical trials and will further Mount Sinai’s mission to provide advanced, personalized treatment and holistic care for patients in all communities. This is the largest gift received by the Mount Sinai Health System for a cancer initiative.
In 2008, a $40 million gift from the family established The Tisch Cancer Institute, which has made advancements in cancer research across basic science, clinical care, and population health.
“Our gift to Mount Sinai more than 13 years ago to create The Tisch Cancer Institute was a result of our family’s passion and commitment to saving lives and advancing the health of all patients battling this chronic disease,” said James S. Tisch, Co-Chairman of the Boards of Trustees of the Mount Sinai Health System. “We have one of the largest and most respected Myeloma programs in the country, and have seen enormous growth in our cancer programs and footprint. We believe that this new gift will transform cancer care and expand access to life-saving breakthroughs, enhancing Mount Sinai’s leadership in cancer treatment and research,” stated Mr. Tisch.
The new Tisch Cancer Hospital, located at 1440 Madison Avenue, will consist of four floors with approximately 20 single-bed rooms on each floor. There will also be a series of innovative clinical spaces designed to ease transitions between various stages of treatment. The hospital is expected to be completed by 2025.
“We are so grateful to Jim and Merryl for their continued and outstanding support of Mount Sinai, and we are deeply honored that the new hospital will bear the Tisch name,” says Kenneth L. Davis, MD, President and Chief Executive Officer of Mount Sinai Health System. “Their ongoing generosity helps us elevate the level of cancer care all patients receive at Mount Sinai.”
A new ad campaign announcing the Tisch Cancer Center was launched during the Stand Up to Cancer telethon on August 21. The telecast featured a pre-recorded message from Elisa Port, MD, Director of the Dubin Breast Center and Chief of Breast Surgery at the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai) and Ajai Chari, MD, Director of Clinical Research in the Multiple Myeloma Program and Associate Director of Clinical Research of the Mount Sinai Cancer Clinical Trials Office at Mount Sinai.
The Mount Sinai Tisch Cancer Center will include the Tisch Cancer Hospital, The Tisch Cancer Institute at Icahn Mount Sinai (a National Cancer Institute designated cancer center which is the highest federal rating for a cancer center), several Cancer Centers of Excellence, and a growing ambulatory cancer network. Patients will have access to more than 250 oncologists, top-tier surgeons, and researchers working side-by-side throughout the New York metropolitan area, as well a full range of comprehensive medical services provided by one of the highest ranked hospitals in New York City and nationally.
“This donation has strengthened our ability to deliver the utmost in cancer research and clinical excellence. We are charting a new course, finding new paths to early detection, and will eventually eradicate this disease so no family has to experience the loss of a loved one to cancer,” says Dennis S. Charney, Anne and Joel Ehrenkranz Dean of Icahn Mount Sinai and President for Academic Affairs at the Mount Sinai Health System. “We are grateful to Jim and Merryl. This gift will have an impact for generations to come.”
“This hospital and center represents a steadfast commitment to provide life-saving and high-quality cancer care for our patients and community,” said Luis Isola, MD, Director of Cancer Clinical Programs and Medical Director of Mount Sinai Cancer Network. “Our patients will have streamlined access to care from outstanding oncologists and specialists in a broad array of specialties. Once completed, it will be a model for 21st century cancer care. We thank the Tisch family for their generous support."
“Creating the new Mount Sinai Tisch Cancer Center to encompass the new hospital, The Tisch Cancer Institute, and cancer care across our growing network and System will be a catalyst for providing and innovating the best cancer care,” said Ramon Parsons, MD, PhD, Director of The Tisch Cancer Institute, Chair of the Department of Oncological Sciences and Ward-Coleman Chair in Cancer Research at Icahn Mount Sinai.
The Tisch Cancer Institute, established in 2008 through a gift by the Tisch Family, today has more than 80 prominent scientists and physicians working to develop innovative and translational research programs in cancer immunology, molecular mechanisms, and prevention and control. The work accomplished at the Tisch Cancer Institute continues to build upon Mount Sinai’s history of revolutionary medical discoveries and outstanding patient care.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.
Mount Sinai Showcases Innovative Cancer Research at 2025 AACR Annual Meeting in Chicago
Apr 24, 2025 View All Press Releases
Study Identifies New Gene That Drives Colon Cancer
Oct 14, 2022 View All Press Releases
Mount Sinai’s Dubin Breast Center Annual Benefit Raises Over $2.5 Million
Feb 08, 2022 View All Press Releases